Clinical phenotyping of a large cohort of patients with myotonic dystrophy type 1: a longitudinal, single-centre study

Introduction Myotonic Dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy, characterized by extreme clinical heterogeneity and multisystem involvement. Identifying homogeneous clinical phenotypes through comprehensive multisystem assessment may improve understanding of disease pathophysiology and enable prognostic stratification. Methods We conducted a single-centre, longitudinal, retrospective observational on a genetically confirmed cohort of 95 DM1 patients followed at the Neuromuscular Diseases Clinic of AOUP, Pisa. Neurological, pulmonary and cardiac parameters were collected from clinical records, with MIRS assessments at baseline and at 1-, 2-, 5-, and 10-year follow-up visits. Results Progressive muscular worsening was documented over follow-up, with 10/58, 19/46, and 11/20 patients worsening at 2, 5, and 10 years, respectively. The proportional-odds assumption for an initial ordinal GEE was not supported (Wald p = 0.0145); threshold-specific models showed greater odds of MIRS ≥4 at 5 years (OR 3.67, 95% CI 1.98–6.81) and 10 years (OR 6.98, 2.59–18.81) compared with baseline. Higher MIRS was associated with lower VC and FEV₁ after age-, sex- and BMI-adjustment. Larger midpoint-estimated CTG expansions were associated withpoorer respiratory function, whereas no clear association with baseline MIRS was observed. No significant associations were observed between the evaluated cardiac parameters and muscular or genetic characteristics. Discussion In DM1, muscular impairment worsened over follow-up and was associated with poorer respiratory function, although different clinical domains did not necessarily change at the same rate. These findings support structured, multidisciplinary longitudinal and highlight the need for further studies of individual prognostic markers.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2026-11-18
DOI
https://doi.org/10.3389/fneur.2026.2005006
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical phenotyping of a large cohort of patients with myotonic dystrophy type 1: a longitudinal, single-centre study

Michele Emdin, Lorenzo Fontanelli, Andrea Barison, Giulia Ricci et al.
2 links
Frontiers in Neurology
Genetic Neurodegenerative Diseases
article

Clinical phenotyping of a large cohort of patients with myotonic dystrophy type 1: a longitudinal, single-centre study

Michele Emdin, Lorenzo Fontanelli, Andrea Barison, Giulia Ricci, Francesca Torri, Gabriele Siciliano, Laura Carrozzi, Federica Di Giorgi
article en

Abstract

Introduction Myotonic Dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy, characterized by extreme clinical heterogeneity and multisystem involvement. Identifying homogeneous clinical phenotypes through comprehensive multisystem assessment may improve understanding of disease pathophysiology and enable prognostic stratification. Methods We conducted a single-centre, longitudinal, retrospective observational on a genetically confirmed cohort of 95 DM1 patients followed at the Neuromuscular Diseases Clinic of AOUP, Pisa. Neurological, pulmonary and cardiac parameters were collected from clinical records, with MIRS assessments at baseline and at 1-, 2-, 5-, and 10-year follow-up visits. Results Progressive muscular worsening was documented over follow-up, with 10/58, 19/46, and 11/20 patients worsening at 2, 5, and 10 years, respectively. The proportional-odds assumption for an initial ordinal GEE was not supported (Wald p = 0.0145); threshold-specific models showed greater odds of MIRS ≥4 at 5 years (OR 3.67, 95% CI 1.98–6.81) and 10 years (OR 6.98, 2.59–18.81) compared with baseline. Higher MIRS was associated with lower VC and FEV₁ after age-, sex- and BMI-adjustment. Larger midpoint-estimated CTG expansions were associated withpoorer respiratory function, whereas no clear association with baseline MIRS was observed. No significant associations were observed between the evaluated cardiac parameters and muscular or genetic characteristics. Discussion In DM1, muscular impairment worsened over follow-up and was associated with poorer respiratory function, although different clinical domains did not necessarily change at the same rate. These findings support structured, multidisciplinary longitudinal and highlight the need for further studies of individual prognostic markers.

Frontiers in NeurologyVol. 17
University of Pisa (IT), Scuola Superiore Sant'Anna (IT), Fondazione Toscana Gabriele Monasterio (IT)
Good health and well-being
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon